M
$ Value
$0
Shares
9,008
Price
$0
Filed
Feb 10
Insider
Name
Viehbacher Christopher
Title
President and CEO
CIK
0001774478
Roles
Director
Officer
Transaction Details
Transaction Date
2026-02-06
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
9,009
Footnotes
The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024. | The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.
Filing Info
Viehbacher Christopher's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-13 | BIIB | A | $0 |
| 2026-02-06 | BIIB | M | $0 |
| 2026-02-06 | BIIB | F | $876K |
| 2026-02-06 | BIIB | M | $0 |
| 2026-02-06 | BIIB | F | $1.3M |
| 2026-02-06 | BIIB | M | $0 |
| 2026-02-06 | BIIB | M | $0 |
| 2025-12-01 | BIIB | M | $0 |
| 2025-12-01 | BIIB | F | $605K |
| 2025-12-01 | BIIB | M | $0 |
Other Insiders at BIIB (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Murphy Nicole
Head of Pharm Ops and Tech
|
$585 | — | 2026-02-13 |
|
ALEXANDER SUSAN H
EVP Chief Legal Officer
|
— | — | 2026-02-13 |
|
Gregory Ginger
EVP, Human Resources
|
— | — | 2026-02-13 |
|
Kramer Robin
Chief Financial Officer
|
— | — | 2026-02-13 |
|
Singhal Priya
Head of Development
|
— | $666K | 2026-02-13 |
|
Viehbacher Christopher
President and CEO
|
— | — | 2026-02-13 |
|
Izzar Rachid
Head of Global Product Strat.
|
— | — | 2026-02-13 |
|
Keeney Adam
Head of Corporate Development
|
— | — | 2026-02-13 |
|
Grogan Jane
Head of Research
|
— | — | 2026-02-13 |
|
Godbout Sean
Chief Accounting Officer
|
— | — | 2026-04-01 |